ALIGN is a digital platform and program of work that works to create a global community of researchers and thought leaders, all committed to gender justice and equality. It provides new research, insights from practice, and grants for initiatives that increase our understanding of – and what works to change – discriminatory gender norms.
Reproductive empowerment (RE) includes people’s ability to participate in public and private discussions and act collectively on reproductive health matters. This database contains examples or literature about sexual and reproductive health (SRH) interventions that address concepts in the RE conceptual model which is found here.
Over the past 25 years, as the HIV epidemic took hold in many countries, a number of observational research studies suggested a possible increased risk of HIV acquisition for women using progestogen-only injectables, particularly DMPA-IM.
The Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial was launched in 2015 to test the comparative risk of HIV acquisition among women using one of the following three contraceptive methods: depo-medroxyprogesterone acetate intramuscular (DMPA-IM), also known as Depo-Provera, two-rod levonorgestrel sub-dermal implant (LNG-Implant), branded as Jadelle, and the copper intrauterine device (Copper-IUD).